• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Grand Rounds

Are Adverse Outcomes More Frequent with Delivery at 40 or 41 Weeks vs 39 Weeks?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Chen et al. (Obstetrics and Gynecology 2019) compared maternal and neonatal morbidity among low-risk, nulliparous full-term women delivered at 39 weeks vs 40 and 41 weeks

METHODS:

  • Population-based cohort study
    • Low-risk
    • Nulliparous women
    • Main exposure: Gestational week at delivery
      • 39, 40, or 41 weeks
  • Primary outcome: Composite neonatal morbidity included any of following
    • Apgar score <5 at 5 minutes
    • Assisted ventilation >6 hours
    • Seizure
    • Mortality (death within 27 days)
  • Secondary outcome: Composite maternal morbidity, included any of the following
    • ICU admission
    • Blood transfusion
    • Uterine rupture
    • Unplanned hysterectomy
  • Statistical analysis
    • Multivariate Poisson regression to estimate association between gestational age and morbidity
    • Primary and secondary outcomes were adjusted for confounders
    • 39 week used as reference

RESULTS:

  • 3.3 million live births included in analysis
    • 43.5% at 39 weeks | 41.4% at 40 weeks | 15.1% at 41 weeks
  • Overall composite neonatal morbidity: 8.8/1000 live births
  • Overall composite maternal morbidity: 2.8/1000 live births

Newborn morbidity

  • When compared to 39 weeks of gestation, neonatal morbidity was higher at
    • 40 weeks: Adjusted relative risk (RR) 1.22 (95% CI, 1.19–1.25)
    • 41 weeks: aRR 1.53 (95% CI, 1.49–1.58)

Maternal morbidity

  • When compared to 39 weeks of gestation, maternal morbidity was higher at
    • 40 weeks: aRR 1.19 (95% CI, 1.14–1.25)
    • 41 weeks: aRR 1.56 (95% CI, 1.47–1.65)

CONCLUSION:

  • Both neonatal and maternal morbidity were higher in 40 and 41 week cohort compared to 39 week reference
  • While composite morbidity rates were overall low, the implications for pregnant women are significant
  • The authors suggest that the findings from this study can be used in shared decision making regarding induction at 39 weeks for women who are nulliparous and at otherwise low risk

Learn More – Primary Sources:

Neonatal and Maternal Morbidity Among Low-Risk Nulliparous Women at 39–41 Weeks of Gestation

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone

Learn More  »

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

Does Extending Pregnancy Beyond 39 weeks in Low-Risk Pregnancies Incur Additional Risk?
Deliver Low Risk Patients at 39 Weeks to Prevent Hypertensive Complications?
Induction vs Expectant Management At and Beyond Term – the Cochrane Review

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site